Brandywine Global Investment Management’s Antares Pharma, Inc. ATRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-1,310,817
| Closed | -$5.37M | – | 785 |
|
|
2022
Q1 | $5.37M | Sell |
1,310,817
-436
| -0% | -$1.79K | 0.04% | 376 |
|
|
2021
Q4 | $4.68M | Buy |
1,311,253
+1,030,664
| +367% | +$3.68M | 0.03% | 417 |
|
|
2021
Q3 | $1.02M | Sell |
280,589
-2,864
| -1% | -$10.4K | 0.01% | 572 |
|
|
2021
Q2 | $1.24M | Sell |
283,453
-18,029
| -6% | -$78.6K | 0.01% | 568 |
|
|
2021
Q1 | $1.24M | Sell |
301,482
-2,735
| -0.9% | -$11.2K | 0.01% | 550 |
|
|
2020
Q4 | $1.21M | Sell |
304,217
-18,176
| -6% | -$72.5K | 0.01% | 520 |
|
|
2020
Q3 | $871K | Buy |
322,393
+33,770
| +12% | +$91.2K | 0.01% | 504 |
|
|
2020
Q2 | $794K | Buy |
288,623
+2,535
| +0.9% | +$6.97K | 0.01% | 520 |
|
|
2020
Q1 | $676K | Buy |
+286,088
| New | +$676K | 0.01% | 537 |
|